Scholarlink

<p>Mitochondrial dysfunction and reactive oxygen species (ROS) accumulation are central to the pathogenesis of <i>Staphylococcus aureus</i>-induced skin and soft tissue infections (SSTIs). NLRP10 has recently been identified as a key regulator of mitochondrial homeostasis and ROS dynamics. To investigate its regulatory role, we established an in vivo model of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA)-induced SSTIs, which demonstrated significant skin lesions, necrosis, inflammatory infiltration, elevated ROS and LDH levels, decreased NAD+/NADH ratio and ATP content, enhanced apoptosis, and upregulated expression of Cleaved caspase-3, Bax, NLRP10, Cleaved caspase-1, ASC, and phosphorylated NF-κB p65. In vitro, using human primary keratinocytes, NLRP10 knockdown was found to exacerbate MRSA-induced mitochondrial ROS increase, loss of membrane potential, and apoptosis, while attenuating LDH release, ATP depletion, and the secretion of IL-1β/IL-18, as well as reducing the expression of Cleaved caspase-1, ASC, and phosphorylated NF-κB p65. Conversely, NLRP10 overexpression combined with the mitochondrial antioxidant MitoQ alleviated mitochondrial damage and apoptosis but significantly enhanced inflammasome activation and NF-κB pathway signaling. These findings collectively demonstrate that NLRP10 mediates its regulatory effects on <i>Staphylococcus aureus</i>-induced SSTIs through targeting ROS-driven mitochondrial dysfunction.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The effect of Staphylococcus aureus targeting ROS-dependent mitochondrial damage activating NLRP10 in inducing skin and soft tissue infection

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月16日

查看全文
  • Yan Chen,
  • Jieqiong Wei,
  • Shanshan Wang,
  • Mengna Wang,
  • Xiaobo Ying,
  • Chuanling Zhang

摘要

Mitochondrial dysfunction and reactive oxygen species (ROS) accumulation are central to the pathogenesis of Staphylococcus aureus-induced skin and soft tissue infections (SSTIs). NLRP10 has recently been identified as a key regulator of mitochondrial homeostasis and ROS dynamics. To investigate its regulatory role, we established an in vivo model of methicillin-resistant Staphylococcus aureus (MRSA)-induced SSTIs, which demonstrated significant skin lesions, necrosis, inflammatory infiltration, elevated ROS and LDH levels, decreased NAD+/NADH ratio and ATP content, enhanced apoptosis, and upregulated expression of Cleaved caspase-3, Bax, NLRP10, Cleaved caspase-1, ASC, and phosphorylated NF-κB p65. In vitro, using human primary keratinocytes, NLRP10 knockdown was found to exacerbate MRSA-induced mitochondrial ROS increase, loss of membrane potential, and apoptosis, while attenuating LDH release, ATP depletion, and the secretion of IL-1β/IL-18, as well as reducing the expression of Cleaved caspase-1, ASC, and phosphorylated NF-κB p65. Conversely, NLRP10 overexpression combined with the mitochondrial antioxidant MitoQ alleviated mitochondrial damage and apoptosis but significantly enhanced inflammasome activation and NF-κB pathway signaling. These findings collectively demonstrate that NLRP10 mediates its regulatory effects on Staphylococcus aureus-induced SSTIs through targeting ROS-driven mitochondrial dysfunction.